Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program

Purpose:Differentiated thyroid cancer (DTC) accounts for approximately 95% of thyroid carcinomas. In the metastatic RAI-refractory disease, chemotherapy has very limited efficacy and is associated with substantial toxicity. With increasing knowledge of the molecular pathogenesis of DTC, novel target...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Balmelli, Catharina, Railic, Nikola, Siano, Marco, Feuerlein, Kristin, Cathomas, Richard, Cristina, Valerie, Güthner, Christiane, Zimmermann, Stefan, Weidner, Sabine, Pless, Miklos, Stenner, Frank, Rothschild, Sacha I.
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5771331/
https://ncbi.nlm.nih.gov/pubmed/29344270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.22318
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados